|
Tsinzerling A.Yu., Mazurov V.I., Inamova O.V., Petrova M.S., Gaydukova I.Z.
Comorbid conditions in patients with psoriatic arthritis and hyperuricemia
|
№1 / 2025
|
|
Musiychuk M.M., Gaydukova I.Z., Mazurov V.I., Inamova O.V., Aliev D.B., Lapin S.V.
Impact of hyperuricemia at the clinical course of systemic lupus erythematosus and comorbid conditions in young and middle-aged female patients
|
№1 / 2025
|
|
Bashkinov R.A., Mazurov V.I., Gaydukova I.Z., Inamova O.V., Petrova M.S.
Features of the course of osteoarthritis in patients with asymptomatic hyperuricemia
|
№1 / 2025
|
|
Sergeeva O.S., Salamatova V.N., Kotova Yu.A., Shevtsov A.N., Shevtsova V.I.
Influence of hyperuricemia at the efficacy of hypolypidemic therapy in patients with chronic forms of ischemic heart disease
|
№6 / 2024
|
|
Shchemeleva E.V., Skorodumova E.A.
Febuxostat: Efficacy and safety of the drug, prospects for application (literature review)
|
№5 / 2024
|
|
Garanin A.A., Lebedev P.A., Paranina E.V.
Hereditary gout in a young woman with allopurinol intolerance
|
№6 / 2023
|
|
Gaydukova I.Z., Mazurov V.I., Inamova O.V., Zinserling A.Yu., Bashkinov R.A.
Increasing of glomeral filtration rate in the setting of serum uric acid normalization in high cardiovascular risk patients – clinical observations
|
№3 / 2023
|
|
Maksudova A.N., Khalfina T.N., Almukhametova A.I.
Patient with hyperuricemia and chronic kidney disease is at the doctor: Peculiarities of curation in accordance with Russian recommendations
|
№3 / 2023
|
|
Borovkova N.Yu., Kurashin V.K., Tokareva A.S., Makarova E.V., Nekrasov A.A., Savitskaya N.N., Mironov M.A.
Hyperuricemia and reduced glomerular filtration rate in the population among Nizhny Novgorod region inhabitants
|
№3 / 2023
|
|
Larina V.N., Fedorova E.V., Sayno O.V., Mironova T.N., Orlov D.A.
The incidence of abdominal obesity and its association with risk factors for cardiovascular disease in middle-aged people
|
№8 / 2022
|
|
Shchemeleva E.V., Skorodumova E.A.
Adherence to therapy in patients with gout
|
№8 / 2021
|
|
Pereverzev A.P., Ostroumova O.D.
Drug-induced hyperuricemia/gout. Part 2: certain medicines, the use of which is associated with an increased risk of developing of these diseases
|
№7 / 2021
|
Русский
